INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 123 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,596 | -30.2% | 14,385 | -19.9% | 0.00% | – |
| Q2 2023 | $8,018 | -71.0% | 17,958 | -46.7% | 0.00% | – |
| Q1 2023 | $27,614 | -42.3% | 33,676 | +9.7% | 0.00% | – |
| Q4 2022 | $47,869 | +127.9% | 30,685 | +153.3% | 0.00% | – |
| Q3 2022 | $21,000 | 0.0% | 12,115 | -2.0% | 0.00% | – |
| Q2 2022 | $21,000 | -55.3% | 12,366 | -6.7% | 0.00% | – |
| Q1 2022 | $47,000 | -34.7% | 13,250 | -8.0% | 0.00% | – |
| Q4 2021 | $72,000 | -35.7% | 14,405 | -8.3% | 0.00% | – |
| Q3 2021 | $112,000 | -52.3% | 15,711 | -38.0% | 0.00% | – |
| Q2 2021 | $235,000 | -69.9% | 25,324 | -69.9% | 0.00% | -100.0% |
| Q1 2021 | $782,000 | +42.2% | 84,232 | +35.5% | 0.00% | +100.0% |
| Q4 2020 | $550,000 | -30.3% | 62,170 | -9.9% | 0.00% | -50.0% |
| Q3 2020 | $789,000 | -55.5% | 68,980 | +4.5% | 0.00% | -60.0% |
| Q2 2020 | $1,773,000 | +809.2% | 66,006 | +150.3% | 0.01% | +400.0% |
| Q1 2020 | $195,000 | +254.5% | 26,366 | +58.6% | 0.00% | – |
| Q4 2019 | $55,000 | +57.1% | 16,625 | -2.3% | 0.00% | – |
| Q3 2019 | $35,000 | -30.0% | 17,025 | 0.0% | 0.00% | – |
| Q2 2019 | $50,000 | +11.1% | 17,025 | +52.7% | 0.00% | – |
| Q4 2018 | $45,000 | -29.7% | 11,152 | -3.7% | 0.00% | – |
| Q3 2018 | $64,000 | +42.2% | 11,582 | 0.0% | 0.00% | – |
| Q2 2018 | $45,000 | -38.4% | 11,582 | -25.3% | 0.00% | – |
| Q1 2018 | $73,000 | +73.8% | 15,495 | +53.5% | 0.00% | – |
| Q4 2017 | $42,000 | -37.3% | 10,095 | +17.5% | 0.00% | – |
| Q2 2017 | $67,000 | -8.2% | 8,595 | -22.1% | 0.00% | – |
| Q1 2017 | $73,000 | -47.5% | 11,030 | -47.4% | 0.00% | -100.0% |
| Q4 2016 | $139,000 | +54.4% | 20,985 | +99.5% | 0.00% | 0.0% |
| Q3 2016 | $90,000 | -69.3% | 10,520 | -66.8% | 0.00% | -50.0% |
| Q2 2016 | $293,000 | -80.3% | 31,690 | -81.4% | 0.00% | -83.3% |
| Q1 2016 | $1,486,000 | +43.4% | 170,599 | +10.6% | 0.01% | +33.3% |
| Q4 2015 | $1,036,000 | +20.9% | 154,199 | +4.0% | 0.01% | +12.5% |
| Q3 2015 | $857,000 | -28.3% | 148,199 | +1.2% | 0.01% | -27.3% |
| Q2 2015 | $1,195,000 | +2243.1% | 146,499 | +2262.9% | 0.01% | – |
| Q1 2015 | $51,000 | +6.2% | 6,200 | +19.2% | 0.00% | – |
| Q4 2014 | $48,000 | +269.2% | 5,200 | +296.9% | 0.00% | – |
| Q3 2014 | $13,000 | -27.8% | 1,310 | -22.9% | 0.00% | – |
| Q2 2014 | $18,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 100,274 | $82 | 0.01% |